V009-2662 Screening compound: 2-{[[3-(4-chlorophenoxy)-2-hydroxypropyl](3-methoxypropyl)amino]methyl}-7-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

V009-2662 Screening compound: 2-{[[3-(4-chlorophenoxy)-2-hydroxypropyl](3-methoxypropyl)amino]methyl}-7-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one
V009-2662 Screening compound: 2-{[[3-(4-chlorophenoxy)-2-hydroxypropyl](3-methoxypropyl)amino]methyl}-7-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-2662
2-{[[3-(4-chlorophenoxy)-2-hydroxypropyl](3-methoxypropyl)amino]methyl}-7-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-2662

Molecular Formula

C25H32ClN3O4S (C25 H32 ClN3 O4 S)

Compound Name

2-{[[3-(4-chlorophenoxy)-2-hydroxypropyl](3-methoxypropyl)amino]methyl}-7-methyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one

IUPAC name

5-({[3-(4-chlorophenoxy)-2-hydroxypropyl](3-methoxypropyl)amino}methyl)-11-methyl-8-thia-46-diazatricyclo[7.4.0.0^{27}]trideca-1(9)2(7)5-trien-3-one

SMILES

CC(CC1)Cc2c1c(C(NC(CN(CCCOC)CC(COc(cc1)ccc1Cl)O)=N1)=O)c1s2

InChI

InChI=1S/C25H32ClN3O4S/c1-16-4-9-20-21(12-16)34-25-23(20)24(31)27-22(28-25)14-29(10-3-11-32-2)13-18(30)15-33-19-7-5-17(26)6-8-19/h5-8,16,18,30H,3-4,9-15H2,1-2H3,(H,27,28,31)

InChI Key

XTEXSJNNNWJCPS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19871384

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

506.07

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.420

Distribution Coefficient, logD

4.420

Water Solubility, LogSw

-4.53

Polar Surface Area

71.146

Acid Dissociation Constant (pKa)

10.38

Base Dissociation Constant (pKb)

4.25

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

52.00

V009-2662 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with V009-2662 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-2662?
Check Price and Availability of V009-2662, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-2662 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-2662
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-2662
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-2662 available by request